EPISODE · May 6, 2026 · 2 MIN
ctDNA in Early Breast Cancer: Prognostic Power vs Clinical Actionability
from TheBrief.Health · host TheBrief.Health
Circulating tumor DNA helps detect minimal residual disease and predict recurrence risk in early breast cancer, but its role in guiding treatment decisions remains promising yet unproven.
What this episode covers
Circulating tumor DNA helps detect minimal residual disease and predict recurrence risk in early breast cancer, but its role in guiding treatment decisions remains promising yet unproven.
NOW PLAYING
ctDNA in Early Breast Cancer: Prognostic Power vs Clinical Actionability
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m